🇬🇧 NHS England to roll out the world’s first #gonorrhoea vaccine! 👏 GARDP welcomes the UK’s leadership on drug-resistant gonorrhoea. But vaccination alone isn’t enough. 📉 With rising resistance, GARDP is working to develop new treatments and ensure access where it’s most

Breaking Through Resistance: A Comparative Review of New Beta-Lactamase Inhibitors (Avibactam, Vaborbactam, Relebactam) Against Multidrug-Resistant Superbugs doi.org/10.3390/antibi…

A Global Survey of Diagnostic Practices in Prosthetic Joint Infections sciencedirect.com/science/articl…

Population-based longitudinal study of Candida bloodstream infection reveals gender and species differences in mortality, recurrence and resistance UQ Medicine David Paterson journalofinfection.com/article/S0163-…

🚩 A milestone in the fight against #AMR Congratulations to Roche on advancing zosurabalpin into Phase 3 trials—a potential first-in-class antibiotic against Carbapenem-resistant Acinetobacter baumannii and other Gram-negative bacteria in over 50 years. This kind of bold

At GARDP, we’re changing the way #antibiotics are developed and accessed by 🛡️ Protecting adults from serious bacterial infections 👶 Helping newborns fight sepsis 💊 Treating drug-resistant gonorrhoea 🌍 Overcoming access barriers 🔬 Advancing new antibiotic discoveries

Kudos and respect to Paul Keating , the only living PM who refused to accept an AC because he believed that honours should be reserved for those whose work in the community went unrecognised and that being PM was significant public recognition. Definitely not a cosplay PM.

Day Zero Diagnostics is proud to announce the acquisition of our technology and substantially all of our assets by bioMérieux, a global leader in infectious disease diagnostics. (1/3)

Interested in respiratory viruses ? Work in primary or hospital care in Australia ? Then this series of meetings might be for you ! Separately events in each major state - so sign up for your local meeting. eventmanagement.eventsair.com/goviral2025/re…

So excited that ADVANCE-ID Network has commenced recruitment into our world first platform trial for carbapenem-resistant Gram negatives! Patrick Harris Jesus Rodriguez Baño

Amazing that 2 large trials using the PRACTical design have recruited their first patients within days of each other. NeoSep in children and TREAT-GNB in adults. Well done Global Antibiotic R&D Partnership (GARDP) and ADVANCE-ID Network

🆕💫Standing on the Shoulders of Imperfect Humans: Adjunctive Therapy for Enterococcus faecalis Infective Endocarditis The authors travel back in time and provide a nuanced critique of the limited seminal evidence underpinning adjunctive therapy for EFIE sciencedirect.com/science/articl…

🚀 Join us in welcoming Dr Abi Manesh to the ADVANCE-ID team! Here’s a brief introduction to get to know him better! #WelcomeOnboard #ADVANCE_ID #AMR #ClinicalTrials #Research #Singapore Abi Manesh

We are pleased to announce that earlier this month, we enrolled the first patient into the CRGNB silo of the TREAT-GNB platform trial! TREAT-GNB was also recently initiated at another two hospital centres in China. Read more: ad-id.co/t1

📢 PhD Scholarship opportunity available! We are currently seeking a PhD candidate to join CEAStAR on a new project that will explore a new technology that combines magnetic nanoparticle capture with DNA nanoball-based sequencing for the identification of bacteria....

Queensland clinicians! Please join us on sat 13th sept for a day discussing all things respiratory virus with some excellent speakers - aiming to improve the management of patients within primary and hospital care and prepare for whatever is on the horizon eventmanagement.eventsair.com/QuickEventWebs…

Welcome Iris! So great to have you sharing your extensive experience with resistant GNBs with us!

I am very excited to share our latest preprint on Profiling of Burkholderia pseudomallei variants derived from Queensland clinical isolates biorxiv.org/content/10.110…

Thanks to Patrick Harris for welcoming me into your lab for this paper 🙌. Also huge thanks to the team who made it possible despite a cyclone (!) and a very limited stay in Brisbane.

Well done Chitra Ravi ! Probe‐capture targeted next‐generation sequencing for pathogen and antimicrobial resistance detection in sepsis - Clinical and Translational Discovery UQ News UQ Medicine onlinelibrary.wiley.com/doi/10.1002/ct…